Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-05-17 @ 3:16 PM
Study NCT ID:
NCT05915351
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-16
First Post:
2023-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
Sponsor:
University of Kansas Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00150104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None